Financials
Financial year 2025
Gross margin
€ 1.2 million
▼ 7% vs 2024
Profit
Caution€ -52,946
▼ 143% vs 2024
Debts
Low€ 129,904
▼ 24% vs 2024
EUROPABIO from Brussel, company number BE0477520310, closed financial year 2025 with a result of € -52,946 after tax. For that financial year EUROPABIO recorded a gross margin of € 1.2 million and equity of € 3.8 million. Compared with financial year 2024, the result moved from € 123,113 to € -52,946. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
What happened at EUROPABIO?
What happened at EUROPABIO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 52,946 (▼ 143% vs 2024). filed late Source: NBB ↗
- Markus STÄMPFLI became a director. NBB
- Ana Maria BRAVO ANGEL became a director. NBB
- Ricardo GENT became a director. NBB
- Wojciech NOWAK became a director. NBB
- Ion AROCENA VELEZ became a director. NBB
- Jessica MARTINSSON became a director. NBB
- New establishment in Brussel. KBO
In short
From € 74,384 profit in 2022 to € 52,946 loss in 2025.
Paid € 70 in corporate taxes since 2022.
Best year ever: 2024, with € 123,113 profit.
On average € 113,600 of value added per employee in 2025.
A new publication or filing at EUROPABIO? We notify you, reason included.
Follow EUROPABIONeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind EUROPABIO are Markus STÄMPFLI, Ana Maria BRAVO ANGEL, Ricardo GENT, Wojciech NOWAK, Ion AROCENA VELEZ and Jessica MARTINSSON.
Directors
According to the 2025 annual accounts
Markus STÄMPFLI
Chairman of the board
since 2025
Ana Maria BRAVO ANGEL
Vice-présidente du Conseil d'Administration
since 2025
Ricardo GENT
Vice-chairman of the board
since 2025
Wojciech NOWAK
Vice-chairman of the board
since 2025
Ion AROCENA VELEZ
Administratrice-Trésorière
since 2025
Jessica MARTINSSON
Vice-présidente du Conseil d'Administration
since 2025
Establishments
Establishment units
Physical locations of this company
Kunstlaan 53 box 8
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
Les Ailes Brisées de Belgique
Club Air France
Association Européenne des Organisateurs de Recherche sous Contrat
Community of European Railway and Infrastructure Companies
€ 2 million gross margin · 2025
CREDIT INNOVATION
+9 more
Details
- Company number
- 0477.520.310
- VAT number
- BE 0477.520.310
- Registered office
- Kunstlaan 53 bus 8, 1000 Brussel
- Names & denominations
- EUROPABIO
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 17 February 2002
- Peppol
- Active · Active since 8 Oct 2025
- Contact
- c.devaux@europabio.org 0473261522
- Activities · NACE
Bedrijfs- en werkgeversorganisaties
Activiteiten van bedrijfs- en werkgeversorganisaties
Markt- en opinieonderzoek
Marktonderzoekbureaus